Evidence map›Paper›PMID 40629452›Full record

ArticleParasites & vectors2025

Toxicity of ivermectin to bed bugs (Cimex hemipterus) and risk factors associated with infestation in Kwale County, coastal Kenya.

Tobias Odongo, Isaiah Omondi, Caroline Wanjiku, Miguel Okoko, Caroline Kiuru, Mercy Kariuki, Isaac Ringera, Bruno Otieno, Festus Mure, Joanna Furnival-Adams and 6 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Tobias OdongoKEMRI: Kenya Medical Research Institute, Nairobi, Kenya.
Isaiah OmondiKEMRI-Wellcome Trust Research Programme: Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Caroline WanjikuKEMRI-Wellcome Trust Research Programme: Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Miguel OkokoKEMRI-Wellcome Trust Research Programme: Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Caroline KiuruISGlobal, Barcelona, Spain.
Mercy KariukiKEMRI: Kenya Medical Research Institute, Nairobi, Kenya.
Isaac RingeraKEMRI-Wellcome Trust Research Programme: Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Bruno OtienoKEMRI: Kenya Medical Research Institute, Nairobi, Kenya.
Festus MureKEMRI-Wellcome Trust Research Programme: Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Joanna Furnival-AdamsISGlobal, Barcelona, Spain.
Almudena Sanz GutierrezISGlobal, Barcelona, Spain.
Rachel OtukoKEMRI-Wellcome Trust Research Programme: Centre for Geographic Medicine Research Coast, Kilifi, Kenya.
Nelly Regina RabinovichISGlobal, Barcelona, Spain.
Joseph MwangangiKEMRI: Kenya Medical Research Institute, Nairobi, Kenya.
Carlos ChaccourISGlobal, Barcelona, Spain.
Marta Ferreira MaiaKEMRI-Wellcome Trust Research Programme: Centre for Geographic Medicine Research Coast, Kilifi, Kenya. mmaia@kemri-wellcome.org.

Funding

UNITAID BOHEMIA
6 · The paper itself

Abstract

backgroundBed bugs (Cimex spp.) are obligate ectoparasites that have long been associated with human dwellings, causing discomfort and psychosocial distress. Conventional control strategies relying on insecticides are increasingly challenged by resistance, necessitating alternative interventions. Ivermectin, an endectocide known to impact various neglected tropical diseases and hematophagous arthropods, is currently being assessed for malaria vector control. This study aimed to evaluate the toxicity of ivermectin on Cimex hemipterus, the predominant bed bug species in Africa, within the framework of the Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) project in Kwale, Kenya.

methodsA cross-sectional survey was conducted in 352 households to obtain information on self-reported bed bug infestations, socioeconomic status, and household characteristics. Bed bugs were collected from 40 infested households. After collection, bed bugs were acclimatized and exposed to blood meals spiked with ivermectin at five concentrations (85 ng/ml, 64 ng/ml, 43 ng/ml, 21 ng/ml, and 11 ng/ml), corresponding to expected serum levels 4 h to 6-7 days following a 400 µg/kg oral dose. Mortality and fecundity were monitored over a 14-day period. Statistical analyses, including Cox proportional hazard models and probit regression, were applied to assess dose-response relationships.

resultsBed bug infestation was common, with 75% of participating households reporting their presence, with infestations being strongly associated with the number of people residing in a household. Ivermectin exposure resulted in significant dose-dependent mortality in Cimex hemipterus, with the higher concentrations (43, 64, and 85 ng/ml) inducing over 90% mortality within 3 days postfeeding. Bed bugs that ingested blood meals containing sublethal doses of ivermectin did not lay eggs. Kaplan-Meier survival analyses demonstrated a clear inverse relationship between ivermectin concentration and bed bug survival.

conclusionsThese findings provide evidence that ivermectin, administered as part of a mass drug administration campaign, could contribute to bed bug control alongside its intended impact on other diseases or vectors. The results underscore the potential for integrated public health approaches leveraging endectocide interventions. Further field evaluations in diverse locations are needed to determine the optimal number of administrations and treatment intervals required for complete infestation elimination.

Indexed as

BedbugsEctoparasitic InfestationsInsecticidesIvermectinAdultAnimalsCross-Sectional StudiesFamily CharacteristicsFemaleHumansKenyaMaleRisk FactorsInsecticidesIvermectinBed bugsCimex hemipterus.Cimex spp.EndectocidesIvermectinKenyaKwale

Identifiers

PMID40629452
PMCPMC12239333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.